World Journal of Surgery

, Volume 33, Issue 7, pp 1545–1546 | Cite as

Limitations of “Classic” Risk Factors to Predict Neoadjuvant Chemotherapy Response for Operable Breast Cancer



  1. 1.
    Shien T, Akashi-Tanaka S, Miyakawa K et al (2008) Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer. World J Surg 33:44–51CrossRefGoogle Scholar
  2. 2.
    Fatouros M, Baltoyiannis G, Roukos DH (2008) The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol 15:21–33PubMedCrossRefGoogle Scholar
  3. 3.
    Ziogas D, Baltogiannis G, Fatouros M et al (2008) Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg 247:714–715PubMedCrossRefGoogle Scholar
  4. 4.
    Roukos DH (2008) HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 358:197PubMedCrossRefGoogle Scholar
  5. 5.
    Roukos DH (2009) Assessing both genetic variation (SNPs/CNVs) and interactions with the environment may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn 9:1–6PubMedCrossRefGoogle Scholar
  6. 6.
    Roukos DH (2008) Linking contralateral breast cancer with genetics. Radiother Oncol 86:139–141PubMedCrossRefGoogle Scholar
  7. 7.
    Roukos DH (2008) Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn 8:587–597PubMedCrossRefGoogle Scholar
  8. 8.
    Roukos DH (2008) Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev Mol Diagn 8:29–39PubMedCrossRefGoogle Scholar
  9. 9.
    Roukos DH (2008) Breast-cancer stromal cells with TP53 mutations. N Engl J Med 358:1636PubMedCrossRefGoogle Scholar
  10. 10.
    Roukos DH (2009) Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer. J Clin Oncol [Epub ahead of print Feb 2, 2009]. doi:10.1200/JCO.2008.20.2812Google Scholar
  11. 11.
    Roukos DH, Lykoudis E, Liakakos T (2008) Genomics and challenges toward personalized breast cancer local control. J Clin Oncol 26:4360–4361PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2009

Authors and Affiliations

  1. 1.Breast Unit, 1st Department of Propaedeutic SurgeryUniversity of AthensAthensGreece

Personalised recommendations